MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Multimodal MRI markers modifications in multiple system atrophy: A longitudinal study

    P. Péran, WG. Meissner, O. Rascol, A. Pavy-Le Traon (Toulouse, France)

    Objective: Using multimodal MRI, the aim of the study was to evaluate brain changes due to disease progression in multiple system atrophy (MSA) patients. Background:…
  • 2018 International Congress

    Differential glial and neuronal response in Lipopolysaccharide induced Parkinson’s disease model: Modulation with Apocyanin and Curcumin

    N. Sharma, B. Nehru (Chandigarh, India)

    Objective: To understand the differential susceptibility of neuronal and glial populations to lipopolysaccharide (LPS) mediated insult in an animal model of PD. Also, to test…
  • 2018 International Congress

    Evaluating long-term effectiveness of carbidopa/levodopa enteral suspension in advanced Parkinson’s Disease patients: PROviDE study design and baseline characteristics

    R. Pahwa, R. Dorsey, P. Kandukuri, Y. Bao, J. Zamudio, I. Pan, Y. Jalundhwala (Kansas City, KS, USA)

    Objective: To evaluate the real-world long-term effectiveness of CLES on advanced PD patients and their caregivers. Background: Carbidopa/levodopa enteral suspension (CLES) was approved in USA…
  • 2018 International Congress

    Does the effect of continuous levodopa infusion treatment for Parkinson’s disease regress as the day progresses?

    I. Thomas, M. Memedi, D. Nyholm, J. Westin (Borlange, Sweden)

    Objective: The goal of this project is to examine if there is evidence to suggest that there is a difference in response to levodopa during…
  • 2018 International Congress

    Can choice of games influence the therapeutic results obtained by training in virtual reality for gait improvement in people with Parkinson’s disease?

    P. Barbosa, A. da Costa, A. Falconi, M. d'Alencar, M E. Piemonte (São Paulo, Brazil)

    Objective: The aim of this study was to compare the efficiency of two different combination of games to improve the gait performance in PPD. Background:…
  • 2018 International Congress

    The efficacy of intensive inpatient rehabilitation treatment in Parkinson’s disease patients

    J. Shiraishi, T. Okazaki, S. Saeki (Fukuoka, Japan)

    Objective: We investigated the efficacy of intensive impatient rehabilitation treatment in Parkinson's disease patients Background: Rehabilitation treatments have beneficial effects in Parkinson’s disease (PD).We determined…
  • 2018 International Congress

    Effectiveness of Rotigotine plus Intensive and Goal-based Rehabilitation versus Rotigotine alone in “de-novo” Parkinsonian subjects: A Randomized Controlled Trial with 18-month Follow-up

    D. Ferrazzoli, P. Ortelli, G. Riboldazzi, R. Maestri, G. Frazzitta (Gravedona ed Uniti, Italy)

    Objective: To evaluate the synergism between Dopamine Replacement Therapy (DRT) and rehabilitation in treating Parkinson's disease (PD), by investigating the short and the long-term effectiveness…
  • 2018 International Congress

    Clinical characteristics of turkish patients with Parkinson’s disease: A retrospective analysis of 428 patients

    B. Gonenli Kocer, E. Ozturk, S. Comoglu (Ankara, Turkey)

    Objective: To evaluate the demographic, motor and non-motor clinical characteristics of Turkish Parkinson’s disease (PD) patients in our Movement Disorders Outpatient Clinic. Background: Although PD…
  • 2018 International Congress

    DIRECT DBS: A Prospective, Multicenter Clinical Study with Double-Blinding for a Directional Deep Brain Stimulation Lead – Intra-visit Impedance Changes

    F. Steigerwald, J. Volkmann, C. Matthies, A. Dalal Kirsch, S. Chabardes, R. de Bie, PR. Schuurman, E. Moro, V. Fraix, S. Meoni, D. Blum, L. Juarez Paz, K. Wynants, N. Van Dyck (Würzburg, Germany)

    Objective: To evaluate impedance changes throughout the course of a programming visit as a part of a larger directional lead exploration study. Background: Historically, DBS…
  • 2018 International Congress

    SURE-PD3 Trial Participant Features prior to Randomization

    E. Macklin, A. Videnovic, C. Lungu, C. Kamp, C. Casaceli, D. Oakes, A. Ascherio, M. Schwarzschild; on behalf of the Parkinson Study Group SURE-PD3_Investigators (Boston, MA, USA)

    Objective: To describe the cohort screened and randomized into the Study of Urate Elevation in Parkinson’s Disease, phase 3 (SURE-PD3) trial (NCT02642393). Background: The SURE-PD3…
  • « Previous Page
  • 1
  • …
  • 22
  • 23
  • 24
  • 25
  • 26
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley